Search
Results: 1
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.
PJ Ross, HS Wasan, D Croagh, M Nikfarjam, N Nguyen, M Aghmesheh, AM Nagrial, D Bartholomeusz, A Hendlisz, T Ajithkumar, C Iwuji, NE Wilson, DM Turner, DC James, E Young, MT Harris
Jan 28, 2022
BACKGROUND: Unresectable locally advanced pancreatic cancer (LAPC) is generally managed with chemotherapy or chemoradiotherapy, but prognosis is poor with a median survival of ∼13 months (or up to 19 months in some studies). We...
(32)P microparticles Brachytherapy local disease control rate locally advanced pancreatic cancer safety profile Adenocarcinoma Adult Albumins Antineoplastic Combined Chemotherapy Protocols Deoxycytidine Fluorouracil Humans Irinotecan Leucovorin Oxaliplatin Paclitaxel Pancreatic Neoplasms Pilot Projects Gemcitabine